Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocCheck AGXTER:AJ91 -0.84%71 Current Ratio is 3.18 as of Dec. 2025, which is 19% above its 10-year median of 2.67. GuruFocus rates XTER:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.52 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 681 Healthcare Providers & Services companies, DocCheck AG ranks better than 79.74% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. DocCheck AG's current ratio for the quarter that ended in Dec. 2025 was 3.18.
DocCheck AG has a current ratio of 3.18. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for DocCheck AG's Current Ratio or its related term are showing as below:
XTER:AJ91'
s Current Ratio Range Over the Past 10 Years
Min: 2.41 Med: 2.67 Max: 3.18
Current: 3.18
During the past 13 years, DocCheck AG's highest Current Ratio was 3.18. The lowest was 2.41. And the median was 2.67.
XTER:AJ91's Current Ratio is ranked better than 79.74% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs XTER:AJ91: 3.18
DocCheck AG (XTER:AJ91) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
DocCheck AG Current Ratio Related Terms
DocCheck AG Current Ratio Historical Data
* Premium members only.
The historical data trend for DocCheck AG's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:AJ91 vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, DocCheck AG's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocCheck AG Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's Current Ratio distribution charts can be found below:
* The bar in red indicates where DocCheck AG's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocCheck AG (XTER:AJ91) has a Current Ratio of 3.18 as of Dec. 2025. This is 19% above median its historical median of 2.67. Over the past decade, DocCheck AG's Current Ratio has ranged from 2.41 to 3.18. According to the industry distribution chart, DocCheck AG ranks #138 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 20.3%.
Is DocCheck AG's Current Ratio too high?
DocCheck AG's current Current Ratio of 3.18 is 19% above median its 10-year median of 2.67. Over the past 10 years, this metric has ranged from a low of 2.41 to a high of 3.18. The Healthcare Providers & Services industry median Current Ratio is 1.47. DocCheck AG's value of 3.18 is 116.3% above this industry median. Based on the distribution chart, DocCheck AG ranks #138 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DocCheck AG ranks #138 out of 681 companies for Current Ratio. This places DocCheck AG in the top 20% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. DocCheck AG's value of 3.18 is 116.3% above this benchmark. Historically, DocCheck AG's own Current Ratio has ranged from 2.41 to 3.18 over the past decade. While the company's 10-year median is 2.67 vs. the industry median of 1.47, DocCheck AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocCheck AG's current Current Ratio of 3.18 is 116.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocCheck AG's current Current Ratio is 3.18, which is 19% above median its own 10-year median of 2.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (XTER:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.52, compared to a current price of €11.80 — trading 23.9% above its estimated fair value. The current Current Ratio is 3.18, which is 19% above median its 10-year median of 2.67 and 116.3% above the Healthcare Providers & Services industry median of 1.47. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For DocCheck AG (XTER:AJ91), the current Current Ratio is 3.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocCheck AG (XTER:AJ91) Overvalued in 2026?
Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued.
The current stock price of €11.80 is trading 23.9% above its estimated GF Value™ of €9.52.
GuruFocus considers DocCheck AG to be Modestly Overvalued.
Key valuation signals for XTER:AJ91:
Current Ratio: 3.18 (19% above median its 10-year median of 2.67)
GF Value™: €9.52 vs. price of €11.80 (23.9% above fair value)
Industry Position: 116.3% above the Healthcare Providers & Services median (#138 of 681)
No single metric tells the full story. See the XTER:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score
Get the complete analysis for XTER:AJ91
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AJ91 has been successfully added to your 
